Showing results (51-60 of 457) with videos related to
Sort By:
Pageof 46
Rheumatology and Therapy|August 9, 2024
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RAVibeke Strand, Shaun Bender, Dorothy McCabeCurrent Pain and Headache Reports|January 5, 2008
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritisCarla R Scanzello, Neal K Moskowitz, Allan GibofskySeminars in Arthritis and Rheumatism|July 22, 2018
Functional impairment measurement in psoriatic arthritis: Importance and challengesPhilip Mease, Vibeke Strand, Dafna GladmanThe Journal of Rheumatology|April 1, 2005
Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Vibeke StrandCurrent Opinion in Rheumatology|March 20, 2008
The role of drug and disease registries in rheumatic disease epidemiologyJoel M Kremer, Allan Gibofsky, Jeffrey D GreenbergClinical Rheumatology|June 5, 2014
Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunitySoumya D Chakravarty, John B Zabriskie, Allan GibofskyCurrent Rheumatology Reports|May 7, 2008
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritisCarla R Scanzello, Neal K Moskowitz, Allan GibofskyNature Reviews. Rheumatology|December 15, 2020
Immunogenicity of biologic agents in rheumatologyVibeke Strand, Joao Goncalves, John D IsaacsNature Reviews. Drug Discovery|December 30, 2006
Biologic therapies in rheumatology: lessons learned, future directionsVibeke Strand, Robert Kimberly, John D IsaacsSeminars in Arthritis and Rheumatism|January 14, 2022
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systemsTore K Kvien, Kashyap Patel, Vibeke StrandPageof 46